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ABSTRACT
Hypertension is a common concern during pregnancy. Beta-blockers are one potential
treatment, but third trimester exposure has correlated with an increased risk of perinatal
events. Nadolol, a nonselective beta blocker, has properties that differ from those of
its selective counterparts, including longer half-life, decreased protein binding, and
renal excretion in the unchanged form. There is very limited data on the use of nadolol
during pregnancy, and its safety has not been completely evaluated. This case study
documents the perinatal outcomes of nadolol use throughout a medical student’s
pregnancy and explores the experience in obtaining and undergoing medical care.
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INTRODUCTION
Hypertension in pregnancy is common with a
prevalence of 5-10%.1 All antihypertensives have
been shown to cross the placenta with substantial
evidence advising against the use of angiotensin
converting enzyme inhibitors (ACEi) and angiotensin
receptor blockers due to potential harm to the
fetus.1,2 Multiple options for treatment exist but
there is currently no consensus as to which agents
are safest. Beta-blockers can be used, but their
safety is controversial due to reports of fetal and
neonatal adverse effects, including intrauterine
growth restriction (IUGR) and neonatal hypoglycemia,
bradycardia, and hypothermia. Nadolol, a
nonselective beta blocker with a long half-life, is
rarely used because of the potential detriment to the
neonate.3
This case involves the use of nadolol during the
pregnancy of a medical student and the resultant
aftermath for the infant. Studies show that over 90%
of medical students feel the need to seek medical
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care and, despite 95% having insurance, only half
actually seek that care.4,5 This patient’s experience
demonstrates the benefits and burdens a student
has in obtaining medical care in an academic
medical center; these include difficulties with access,
confidentiality, financial strain and intrapersonal
strain.4-6
CASE REPORT
A 24-year-old primigravida in her third year of
medical school had been treated with nadolol since
18 years of age for hypertension and migraine
headaches. Aware of the dangers of beta blockers
during pregnancy, she stopped her medication upon
becoming pregnant. Cessation caused headaches,
palpitations, tachycardia and dizziness. After failing
other beta blockers (atenolol and propranolol), the
medication was restarted, despite little published
evidence. During the pregnancy, the dose was
adjusted based upon her cardiac output, as measured
by maternal impedance cardiography, which allowed
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tailoring the dose of her medication to her cardiac
output. The dose ranged from 40 mg daily initially
to a maximum of 120 mg at 12 weeks gestation,
before settling on 100 mg daily. Blood pressures
remained satisfactory throughout her pregnancy and
symptomatology improved with dose adjustments.

apneic episodes until the next day. All follow-up
outpatient visits since have been normal since his
discharge on day five of life.

A two-vessel cord was diagnosed by ultrasound
at 18 weeks. Nine weeks later, fetal premature
atrial contractions were suspected from irregular
heartbeats on fetal monitoring and confirmed
with fetal echocardiogram. By 33 weeks, her son’s
estimated size, which had been normal, decreased
to near growth restricted levels (15th percentile).
Over the next five weeks, she continued weekly
viability testing and periodic growth monitoring.
An induction was planned at 38 weeks due to
the chronic hypertension and decreasing growth
parameters. She delivered a son via vaginal delivery.
He weighed 2,675 grams (7th percentile) and
APGAR scores were 8 and 9 at one and five minutes,
respectively. A two-vessel cord was the only noted
anomaly. Her last dose of nadolol had been 30 hours
before delivery.

Chronic hypertension, defined as systolic pressures
of >140 mmHg and/or diastolic pressures >90
mmHg, either precedes pregnancy, is present before
the twentieth week of gestation, or persists for
longer than 12 weeks postpartum.2 Mild to moderate
hypertension in pregnancy is not usually treated.1,2
Severe hypertension (systolic BP >160 mmHg and/
or diastolic BP >110 mmHg) requires treatment to
reduce the incidence of maternal stroke. Multiple
options for treatment exist and all should be
assumed to cross placenta, including methyldopa,
calcium channel blockers, hydralazine, thiazide
diuretics, clonidine, and beta blockers.1

Two hours following delivery, her son was placed
in a warmer after being found with a temperature
of 96.6 degrees. Additionally, despite effective
breastfeeding immediately after delivery, he required
formula supplementation after being found to
be hypoglycemic with a glucose of 36 mg/dl. He
was returned to his mother four hours later, and
he appeared flawless. Soon afterward however,
while nursing he appeared dusky and lethargic.
She immediately called for the nurses. Upon their
assessment, an irregular bradycardic heart rate,
hypoglycemia (glucose 31 mg/DL) and hypothermia
(temperature 96.9 degrees) were seen before he was
transferred to the neonatal intensive care unit (NICU).
In the NICU, he was placed in an incubator. Ampicillin
and gentamycin were started until blood cultures
were negative at 48 hours. Intravenous dextrose
and water was required for his hypoglycemia despite
intermittent feeding. The electrocardiogram (ECG)
showed prolonged corrected QT interval and an
irregular heart rhythm through seventeen hours of
life and did not normalize until day two of life. He
continued to have hypoglycemia, hypothermia, and
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DISCUSSION

Beta blockers are inexpensive, readily available
and do not appear to be teratogenic.1 Conversely,
they are associated with fetal growth restriction,
premature labor, neonatal bradycardia,
hypoglycemia, and apnea.3 Nadolol, a nonselective
beta-blocker, acts at both β1 receptors, decreasing
cardiac and renal sympathetic output, and β2
receptors, causing increased systemic vascular
resistance but carry the side effects of constriction of
airway smooth muscle.1 It is a category C medication
in pregnancy and generally considered safe after the
first trimester. Third trimester exposure however, has
correlated with an increased risk of perinatal events
and functional, rather than anatomic, neonatal
disorders.7
Growth restriction is a well-known gestational effect
of beta-blockers.2 The risk of IUGR, seizures, sepsis,
and respiratory distress syndrome are higher in
infants born to mothers treated with beta-blockers.
Decreased fetal circulation may contribute to
development of small for gestational age infants.8
Oakes et al demonstrated that propranolol,
another non-selective beta blocker, can cause an
18% decrease in umbilical cord blood flow. It is
reasonable that decreased nutrition from decreased
umbilical cord blood flow could contribute to
growth restrictions.9
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Postnatal complications can also occur.
Hypoglycemia is a well-established effect in infants
born to mothers treated with beta-blockers. Low
glucose can be attributed to the infant’s low birth
weight and fetal distress during birth,3 but betablockade is known to interfere with metabolic
and autonomic responses to hypoglycemia by
reducing insulin sensitivity and release. Blocking
catecholaminergic promotion of glycogenolysis may
also increase the risk of hypoglycemia in instances
when glycogen stores are already limited, as in low
birth weight infants.10,11
Nadolol itself has different characteristics compared
to other beta-blockers. Serum concentrations have
been shown to be higher at 12 and 38 hours after
delivery than in cord blood. Nadolol’s increased
effects can be explained in three ways. Primarily,
neonatal hemoconcentration and redistribution
of the tissue-sequestered drug levels increase
postnatally. Secondarily, it is more active as it has
a longer half-life and is only 30% protein bound
(compared to 90% for propranolol). Finally, nadolol
is excreted unchanged in the kidneys. Retention
can occur by a decreased glomerular filtration in
the first days of life.3 All these factors can cause the
natural effects of beta blockade to persist. This
case demonstrates that the use of nadolol during
pregnancy carries risk and that adverse effects will
become more prevalent hours after, rather than
immediately after, birth.
Like that of many parents of infants in the NICU,
this birth story was drastically different than
expected. As the patient, however, her experience
was further altered from her accustomed role of a
medical student participating in rounds. Studies
show that medical students’ stress in obtaining
medical care exceeds that of the general population
in several areas.4 The primary cited deterrents are
access to care and financial strain.4,5 These specific
concerns were perceived to be true in this case
as routine obstetric office hours conflicted with
required rotations. Despite regulations that allowed
for time to obtain medical care, fear of missing
educational rotations and the accompanying stigma
from supervising residents and attendings were
perceived. Financial burdens also were felt. Even
with a short stay in the NICU, and despite being
on her parents insurance, the hospital bill was in
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the thousands of dollars, placing financial strain on
their family. An option to navigate these barriers of
accessibility and cost is informal consultation. 46.7%
of fourth year medical students have been shown to
obtain informal medical advice through colleagues
for easier access.4,5 In a highly proceduralized field,
this was not an option.
Student-patients also cite strain on interpersonal
relationships as an impediment to seeking medical
care.4-6 For her, this was multifactorial and presented
challenges as well as benefits. Confidentiality was
non-existent. Every visit brought her face to face
with multiple classmates privy to many private
details of her case. Also the burden of knowledge
weighed heavily upon her. Overhearing nurses
discuss the strangeness of the heart tracings,
not knowing she was a medical student who
understood all they said, increased her anxiety.
Information was explained in technical terms by
those who knew her training and left her with the
responsibility of translating the medical jargon to
an anxious husband. Feeling the need to censor
some information caused her to carry an unequal
portion of the knowledge burden. To compound
that stress, the specter of believing that she should
have prevented the entire situation haunted her and
questions were left unasked as she worried that her
physicians would think less of her knowledge base.
Together, all of these factors create an unmet need
for care of medical students that rivals the rates of
at-risk patient populations.4 While adjusting to these
barriers, she recognized some benefits to being a
student during her patient experience. Through it
all, two close classmates were rotating through the
NICU, who were able to spend extra time relaying the
NICU team’s concerns and plans to the family.
When reflecting on her birth story, this student
remains optimistic that her future patients will
benefit from the experience. Playing the role of
medical student-patient presented transformative
and poignant moments. These contributed to her
growth and development, both personally and
professionally. When medical student–patients
embrace the power of these moments, they are
presented with unique opportunities to become
permeated with empathy, ensuring their future
patients will be better treated and respected.
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CONCLUSION
Resources for detecting and correcting the
predictable metabolic and hemodynamic
abnormalities associated with beta-blockade in
the newborn should be immediately available, and
nadolol should be avoided in pregnancy when
safer options are available. Additionally, medical
educators and teaching institutions should develop
inexpensive and confidential health services that
fit with students’ demanding schedules. With the
correct experiences, student-patients can embrace
and integrate their personal health experiences and
provide more compassionate care to their patients.
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